AEON Biopharma, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
AEON, AEON-WT on NYSE
Location
5 Park Plaza, Suite 1750, Irvine, California

Insiders trading volume in the past year

AEON Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Priveterra Sponsor, LLC 10%+ Owner $139 M Jul 21, 2023
Strathspey Crown Holdings Group, LLC 10%+ Owner $20.3 M -$73.8 M -78.4% Aug 11, 2023
Palmisano Robert J Director, 10%+ Owner Mar 19, 2024
Jost Fischer Director Mar 19, 2024
Eric G. Carter Director Mar 19, 2024
Shelley Thunen Director Mar 19, 2024
Jennifer Sy Principal Accounting Officer May 17, 2024
Seongsoo Park Director Apr 12, 2024
Chad Oh Chief Medical Officer Mar 19, 2024
Alexander Wilson Exec Vp, Clo & Corp Secretary Mar 19, 2024
Daewoong Co., Ltd 10%+ Owner Apr 12, 2024
Marc Forth CHIEF EXECTUIVE OFFICER, Director Mar 19, 2024
Peter A. Reynolds Chief Financial Officer Jul 21, 2023
Barclays Plc 10%+ Owner Feb 20, 2023

Recent Insider Transactions by Companies or Individuals for AEON Biopharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership